FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029310657> ?p ?o ?g. }

• W2029310657 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCPoly [ADP-ribose] polymerase (PARP) has been recognized as a potential molecular target in cancer therapy. PARP inhibitors have been evaluated in clinical trials, both in combination with DNA damaging chemotherapy, and also as single agents in patients with BRCA deficiencies. However, there are problems associated with the clinical applicability of PARP inhibitors that include theoretical genotoxicity of these DNA damage repair inhibitors, and increased toxicity in combination with chemotherapy. Therefore targeted delivery of PARP inhibitors selectively to cancer cells would be clinically beneficial.Diazeniumdiolate-based nitric oxide (NO)-releasing prodrugs developed in our laboratory have proven effective as anticancer agents in a number of in vitro and in vivo models. The lead prodrug JS-K exhibits a multifaceted mechanism of action that includes generation of oxidative/nitrosative stress and DNA damage. We hypothesized that inhibiting PARP may increase effectiveness of JS-K. More importantly, creating a PARP inhibitor prodrug that is activated specifically in the cancer cell could diminish dose-limiting adverse events observed in clinical trials.Using structure-based molecular modeling approaches we have designed and synthesized novel diazeniumdiolate/PARP inhibitor hybrid prodrugs that are activated by glutathione S-transferase P1 (GSTP1), an enzyme frequently overexpressed by cancer cells. This GSTP1-catalyzed activation allows for the selective delivery of nitric oxide and PARP inhibitor simultaneously to the cancer cell. Biological evaluation of the prodrugs in vitro in lung adenocarcinoma and leukemia cells reveals that their mechanism of action involves oxidative/nitrosative stress associated with NO release and depletion of cellular GSH, leading to DNA strand break damage. The compounds induce aryl-mediated crosslinking glutathionylation of cellular thiols that is irreversible, and may lead to observed endoplasmic reticulum (ER) stress. The tumor suppressor p53 pathway is involved in cells bearing wildtype p53. We have also observed the activation of stress kinases p38 and SAPK/JNK. All of the above events led to initiation of apoptosis through both intrinsic and extrinsic pathways.Cancer cells often exhibit specific stress-related phenotypes, caused by insults such as reactive oxygen species, DNA damage, metabolic stress, or ER stress, and agents that further enhance these stresses could be developed as potential therapies. GSTP1-activated diazeniumdiolate/PARP inhibitor hybrid prodrugs selectively induce cancer cell death through ROS/DNA damage and ER stress overload, leading to apoptosis.Citation Format: Anna E. Maciag, Joseph E. Saavedra, Ryan J. Holland, Youseung Kim, Vandana Kumari, Christina E. Luthers, Waheed S. Sehareen, Xinhua Ji, Lucy M. Anderson, Larry K. Keefer. GSTP1-activated nitric oxide-releasing/PARP inhibitor hybrid prodrugs induce cancer cell death through ROS/RNS, DNA damage, ER stress, and apoptosis. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3334. doi:10.1158/1538-7445.AM2013-3334" @default.
• W2029310657 created "2016-06-24" @default.
• W2029310657 creator A5000314948 @default.
• W2029310657 creator A5002271964 @default.
• W2029310657 creator A5002470025 @default.
• W2029310657 creator A5037710598 @default.
• W2029310657 creator A5045226105 @default.
• W2029310657 creator A5069231811 @default.
• W2029310657 creator A5069348197 @default.
• W2029310657 creator A5069407758 @default.
• W2029310657 creator A5076715400 @default.
• W2029310657 creator A5078389294 @default.
• W2029310657 date "2013-04-15" @default.
• W2029310657 modified "2023-09-25" @default.
• W2029310657 title "Abstract 3334: GSTP1-activated nitric oxide-releasing/PARP inhibitor hybrid prodrugs induce cancer cell death through ROS/RNS, DNA damage, ER stress, and apoptosis." @default.
• W2029310657 doi "https://doi.org/10.1158/1538-7445.am2013-3334" @default.
• W2029310657 hasPublicationYear "2013" @default.
• W2029310657 type Work @default.
• W2029310657 sameAs 2029310657 @default.
• W2029310657 citedByCount "0" @default.
• W2029310657 crossrefType "proceedings-article" @default.
• W2029310657 hasAuthorship W2029310657A5000314948 @default.
• W2029310657 hasAuthorship W2029310657A5002271964 @default.
• W2029310657 hasAuthorship W2029310657A5002470025 @default.
• W2029310657 hasAuthorship W2029310657A5037710598 @default.
• W2029310657 hasAuthorship W2029310657A5045226105 @default.
• W2029310657 hasAuthorship W2029310657A5069231811 @default.
• W2029310657 hasAuthorship W2029310657A5069348197 @default.
• W2029310657 hasAuthorship W2029310657A5069407758 @default.
• W2029310657 hasAuthorship W2029310657A5076715400 @default.
• W2029310657 hasAuthorship W2029310657A5078389294 @default.
• W2029310657 hasConcept C108215921 @default.
• W2029310657 hasConcept C121608353 @default.
• W2029310657 hasConcept C126322002 @default.
• W2029310657 hasConcept C143425029 @default.
• W2029310657 hasConcept C178790620 @default.
• W2029310657 hasConcept C181199279 @default.
• W2029310657 hasConcept C182979987 @default.
• W2029310657 hasConcept C185592680 @default.
• W2029310657 hasConcept C2778480876 @default.
• W2029310657 hasConcept C2779138821 @default.
• W2029310657 hasConcept C502942594 @default.
• W2029310657 hasConcept C519581460 @default.
• W2029310657 hasConcept C552990157 @default.
• W2029310657 hasConcept C55493867 @default.
• W2029310657 hasConcept C71924100 @default.
• W2029310657 hasConcept C82381507 @default.
• W2029310657 hasConcept C96232424 @default.
• W2029310657 hasConcept C98274493 @default.
• W2029310657 hasConceptScore W2029310657C108215921 @default.
• W2029310657 hasConceptScore W2029310657C121608353 @default.
• W2029310657 hasConceptScore W2029310657C126322002 @default.
• W2029310657 hasConceptScore W2029310657C143425029 @default.
• W2029310657 hasConceptScore W2029310657C178790620 @default.
• W2029310657 hasConceptScore W2029310657C181199279 @default.
• W2029310657 hasConceptScore W2029310657C182979987 @default.
• W2029310657 hasConceptScore W2029310657C185592680 @default.
• W2029310657 hasConceptScore W2029310657C2778480876 @default.
• W2029310657 hasConceptScore W2029310657C2779138821 @default.
• W2029310657 hasConceptScore W2029310657C502942594 @default.
• W2029310657 hasConceptScore W2029310657C519581460 @default.
• W2029310657 hasConceptScore W2029310657C552990157 @default.
• W2029310657 hasConceptScore W2029310657C55493867 @default.
• W2029310657 hasConceptScore W2029310657C71924100 @default.
• W2029310657 hasConceptScore W2029310657C82381507 @default.
• W2029310657 hasConceptScore W2029310657C96232424 @default.
• W2029310657 hasConceptScore W2029310657C98274493 @default.
• W2029310657 hasLocation W20293106571 @default.
• W2029310657 hasOpenAccess W2029310657 @default.
• W2029310657 hasPrimaryLocation W20293106571 @default.
• W2029310657 hasRelatedWork W1552048956 @default.
• W2029310657 hasRelatedWork W2014828070 @default.
• W2029310657 hasRelatedWork W2016647487 @default.
• W2029310657 hasRelatedWork W2037176049 @default.
• W2029310657 hasRelatedWork W2144884432 @default.
• W2029310657 hasRelatedWork W2295644844 @default.
• W2029310657 hasRelatedWork W2312489336 @default.
• W2029310657 hasRelatedWork W2472828346 @default.
• W2029310657 hasRelatedWork W2565187888 @default.
• W2029310657 hasRelatedWork W2565420281 @default.
• W2029310657 hasRelatedWork W2566948162 @default.
• W2029310657 hasRelatedWork W2692187466 @default.
• W2029310657 hasRelatedWork W2764283066 @default.
• W2029310657 hasRelatedWork W2780443201 @default.
• W2029310657 hasRelatedWork W2891567077 @default.
• W2029310657 hasRelatedWork W2978746526 @default.
• W2029310657 hasRelatedWork W3131461189 @default.
• W2029310657 hasRelatedWork W3195721805 @default.
• W2029310657 hasRelatedWork W2248337154 @default.
• W2029310657 hasRelatedWork W2566346400 @default.
• W2029310657 isParatext "false" @default.
• W2029310657 isRetracted "false" @default.
• W2029310657 magId "2029310657" @default.
• W2029310657 workType "article" @default.